These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 7480549
1. Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects. Fleishaker JC, Garzone PD, Chambers JH, Sirocco K, Weingartner H. Psychopharmacology (Berl); 1995 Jul; 120(2):169-76. PubMed ID: 7480549 [Abstract] [Full Text] [Related]
9. Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humans. Golden PL, Warner PE, Fleishaker JC, Jewell RC, Millikin S, Lyon J, Brouwer KL. Clin Pharmacol Ther; 1994 Aug; 56(2):133-41. PubMed ID: 8062489 [Abstract] [Full Text] [Related]
11. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. File SE, Pellow S. Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006 [Abstract] [Full Text] [Related]
12. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression. O'Connor WT, Earley B, Leonard BE. Br J Clin Pharmacol; 1985 Nov; 19 Suppl 1():49S-56S. PubMed ID: 2859878 [Abstract] [Full Text] [Related]
13. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Owens MJ, Bissette G, Nemeroff CB. Synapse; 1989 Nov; 4(3):196-202. PubMed ID: 2575286 [Abstract] [Full Text] [Related]
14. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Hart RP, Colenda CC, Hamer RM. Am J Psychiatry; 1991 Jan; 148(1):73-7. PubMed ID: 1984710 [Abstract] [Full Text] [Related]
16. The pharmacokinetics and pharmacodynamics of adinazolam: multi-ethnic comparisons. Ajir K, Smith M, Lin KM, Fleishaker JC, Chambers JH, Anderson D, Nuccio I, Zheng Y, Poland RE. Psychopharmacology (Berl); 1997 Feb; 129(3):265-70. PubMed ID: 9084065 [Abstract] [Full Text] [Related]
17. The lack of effect of smoking on the pharmacokinetics and pharmacodynamics of adinazolam and N-demethyladinazolam. Chambers JH, Fleishaker JC. Biopharm Drug Dispos; 1994 May; 15(4):263-72. PubMed ID: 8068865 [Abstract] [Full Text] [Related]
18. Behavioral effects of alprazolam in humans. Kelly TH, Foltin RW, Serpick E, Fischman MW. Behav Pharmacol; 1997 Feb; 8(1):47-57. PubMed ID: 9833000 [Abstract] [Full Text] [Related]
19. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam. Busto UE, Kaplan HL, Wright CE, Gomez-Mancilla B, Zawertailo L, Greenblatt DJ, Sellers EM. J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134 [Abstract] [Full Text] [Related]
20. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects. Allen D, Curran HV, Lader M. Eur J Clin Pharmacol; 1991 Dec; 40(4):355-62. PubMed ID: 2050170 [Abstract] [Full Text] [Related] Page: [Next] [New Search]